


16S rRNA Sequencing: Discover the Advantages of Long-Read Sequencing
CeGaT is expanding its Research and Pharma Solutions product…

Our Service for Your Clinical Study: Benefit from CeGaT’s Many Years of Experience
Our service provides you with our expertise in next-generation…

Expansion of the Diagnostic Panel for Fertility
The Diagnostic Panel for Fertility has been expanded by 68 genes…

Studies confirm: Examination of tumor tissue only without comparing it to normal tissue can lead to misdiagnosis and incorrect treatment decisions
International experts agree: tumor tissue and normal tissue…

Illumina NovaSeq™ X Plus: CeGaT is One of the First Companies to Order Illumina’s Brand New Sequencer
CeGaT is expanding its NGS laboratory with the brand new NovaSeq™…

Update: CeGaT Enhances Tumor Diagnostics
CeGaT has comprehensively revised its in-house tumor diagnostics…

Update of the Diagnostic Panel for Cardiac Diseases: New overarching gene set for cardiac arrhythmias
The Diagnostic Panel for Cardiac Disease has been revised based…

New CancerPrecision® Report including a Graphical Representation of Results and Detailed Information on Applicable Drugs
CeGaT’s new tumor report has been completely revised and raised…
Genetic Diagnostics
Research & Pharma Solutions

CeGaT is a provider of genetic diagnostics and NGS services. The company is based in Tübingen, Germany and is accredited according to CAP, CLIA, DIN EN ISO 15189 and DIN EN ISO 17025.